MEDICAL DEVICE COMPLIANCE, SIMPLIFIED

For the Compliance-Conscious, and Audit-Anxious

Talk to a Regulatory Expert

1,000+

Regulatory Submissions across the UK and EU

Reviewed by

over 20

Different Notified Bodies

10+ years

Supporting Clients Across Full Device Lifecycles

  • Headshot of a senior regulatory leader supporting SciMed's medical device expertise.

    "SciMed has been a trusted partner since day one. Their clinical evaluation expertise gave us confidence through multiple audits, and their reliability has made them an extension of our own team."

    James Davis - Head of Quality and Regulatory; Caristo Diagnostics

  • Headshot of a co-founder endorsing SciMed's regulatory solutions.

    "They understood where we were and what we needed; no oversell, just solid work delivered with minimal fuss. It gave us confidence in our classification and next steps."

    Miles Payling - Co-Founder; C the Signs

Clinical Evaluation Clinical Evaluation

Clinical Evaluation under EU MDR doesn’t have to feel like a constant audit risk. SciMed helps you identify evidence gaps early, strengthen your Clinical Evaluation Report, and face regulators with confidence, not last-minute panic.

Our Service Brands

Explore our Clinical Evaluation Support
Blog
EU MDR Clinical Evaluation for MedTech Start-Ups
EU MDR Clinical Evaluation for MedTech Start-Ups

For MedTech start-ups, clinical evaluation under the EU MDR is no longer a box-ticking exercise - it’s a strategic part of product development. By planning early, leveraging existing evidence, and embedding regulatory thinking from day one, companies can turn compliance into a competitive advantage and a pathway to credible market entry.

Read More →
Proving Safety Without Clinical Trials
Proving Safety Without Clinical Trials

This article outlines how clinical evaluation under the EU MDR can, in certain cases, be conducted without new clinical trials, and explains the regulatory pathways, evidence requirements, and role of PMCF in demonstrating safety and performance.

Read More →
MDR Clinical Data in 2025
MDR Clinical Data in 2025

This article outlines the types of clinical data sources that are accepted, identifies common sources of non-compliance, and provides practical guidance for building a robust, compliant clinical evidence strategy under the MDR framework.

Read More →
How to Prepare a Clinical Evaluation Plan Aligned with MDR Annex XIV
How to Prepare a Clinical Evaluation Plan Aligned with MDR Annex XIV

Under MDR Annex XIV, the CEP is your anchor document. Define scope, map data, integrate risk and PMS, and show foresight. A robust CEP reassures notified bodies and builds a sustainable compliance framework for product safety and performance.

Read More →
How to Update your Clinical Evaluation for Legacy Devices
How to Update your Clinical Evaluation for Legacy Devices

MDR demands stronger clinical justification for legacy devices. Whether relying on WET status, Article 61(10), or targeted PMCF, manufacturers need structured Clinical Evaluation planning to demonstrate compliance and safeguard CE certification.

Read More →
Is Your Clinical Evaluation MDR-Ready?
Is Your Clinical Evaluation MDR-Ready?

Is your Clinical Evaluation ready for MDR scrutiny?
This expert guide walks regulatory and clinical affairs professionals through the latest EU MDR expectations under Article 61 and Annex XIV—covering GSPR alignment, evidence standards, equivalence justifications, and audit-readiness strategies.

Read More →
UK PMS Regulations vs EU MDR
UK PMS Regulations vs EU MDR

With the right updates, existing MDR-compliant systems can be efficiently adapted to meet the new MHRA requirements.

Read More →

Latest Insights

About Us

SciMed Consultancy Ltd partners with medical device and IVD companies across the globe to deliver clear, defensible regulatory solutions across the entire product lifecycle. Our expertise spans clinical evaluation, performance evaluation, post-market surveillance & maintenance and regulatory strategy; supporting compliant market access in the EU and UK.